Insider Transactions in Q4 2020 at Cyclo Therapeutics, Inc. (CYTH)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2020
|
Francis Patrick Ostronic Director |
BUY
Open market or private purchase
|
Direct |
30,000
+12.56%
|
$120,000
$4.64 P/Share
|
|
Dec 11
2020
|
N Scott Fine Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+16.71%
|
-
|
|
Dec 11
2020
|
William S Shanahan Director |
BUY
Open market or private purchase
|
Direct |
20,000
+23.9%
|
-
|
|
Dec 11
2020
|
Randall M. Toig Director |
BUY
Open market or private purchase
|
Direct |
10,000
+22.69%
|
-
|
|
Dec 11
2020
|
Markus Sieger Director |
BUY
Open market or private purchase
|
Direct |
15,000
+17.1%
|
-
|
|
Dec 11
2020
|
Sharon Hemond Hrynkow Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+11.98%
|
-
|
|
Dec 11
2020
|
Jeffrey Tate Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+24.8%
|
-
|
|
Nov 25
2020
|
Joshua M Fine Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+2.14%
|
$0
$0.08 P/Share
|
|
Nov 23
2020
|
Joshua M Fine Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+1.47%
|
$0
$0.08 P/Share
|